Maria Wróbel Selected Research

3-mercaptopyruvate sulphurtransferase

7/2020	Murine cellular model of mucopolysaccharidosis, type IIIB (MPS IIIB) - A preliminary study with particular emphasis on the non-oxidative l-cysteine metabolism.
9/2018	Inhibition of Human Neuroblastoma Cell Proliferation by N-acetyl-L-cysteine as a Result of Increased Sulfane Sulfur Level.
4/2017	Similar effect of sodium nitroprusside and acetylsalicylic acid on antioxidant system improvement in mouse liver but not in the brain.
12/2014	Is development of high-grade gliomas sulfur-dependent?
6/2011	The expression and activity of cystathionine-γ-lyase and 3-mercaptopyruvate sulfurtransferase in human neoplastic cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Wróbel Research Topics

Disease

5	Neoplasms (Cancer) 12/2021 - 12/2014
5	Neuroblastoma 09/2018 - 06/2011
3	Rare Diseases (Rare Disease) 03/2022 - 12/2019
3	Mucopolysaccharidosis III (Sanfilippo Syndrome) 03/2022 - 12/2019
3	Astrocytoma (Pilocytic Astrocytoma) 06/2018 - 06/2011
3	Glioblastoma (Glioblastoma Multiforme) 01/2018 - 01/2017
2	Hypertension (High Blood Pressure) 08/2022 - 01/2021
1	Mucopolysaccharidoses 03/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022
1	Leukemia 01/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022
1	Experimental Melanoma 12/2021
1	Adenocarcinoma 12/2021
1	Osteosarcoma (Osteogenic Sarcoma) 12/2021
1	Pancreatitis 12/2019
1	Portal Hypertension 01/2018
1	Hypotension (Low Blood Pressure) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Cardiotoxicity 10/2017
1	Body Weight (Weight, Body) 04/2017
1	Brain Neoplasms (Brain Tumor) 12/2014
1	Glioma (Gliomas) 12/2014
1	Gamma-cystathionase deficiency 01/2014
1	Melanoma (Melanoma, Malignant) 06/2011
1	Prostatic Neoplasms (Prostate Cancer) 11/2004

Drug/Important Bio-Agent (IBA)

7	SulfurIBA 08/2022 - 12/2014
6	Cysteine (L-Cysteine)FDA Link 03/2022 - 01/2014
5	3-mercaptopyruvate sulphurtransferaseIBA 07/2020 - 06/2011
5	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 12/2019 - 01/2014
4	sulfur-32IBA 08/2022 - 12/2014
4	CystathionineIBA 07/2020 - 06/2011
3	EnzymesIBA 03/2022 - 12/2019
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2017
3	Thiosulfate Sulfurtransferase (Rhodanese)IBA 07/2020 - 12/2014
3	Sulfhydryl Compounds (Thiols)IBA 07/2020 - 11/2017
3	Cystathionine gamma-Lyase (Cysteine Desulfhydrase)IBA 06/2018 - 12/2014
2	Acetylglucosaminidase (NAGase)IBA 03/2022 - 12/2019
2	alpha-N-acetyl-D-glucosaminidase (alpha-N-acetylglucosaminidase)IBA 03/2022 - 07/2020
2	Glutathione Disulfide (GSSG)FDA LinkGeneric 07/2020 - 12/2014
2	LyasesIBA 07/2020 - 06/2011
2	Glutathione (Reduced Glutathione)IBA 12/2014 - 01/2014
1	Heparitin Sulfate (Heparan Sulfate)IBA 03/2022
1	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 01/2022
1	SulfurtransferasesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	4-trifluoromethylsalicylic acid (HTB)IBA 12/2021
1	Hexosaminidases (Hexosaminidase)IBA 07/2020
1	Cystine (L-Cystine)IBA 07/2020
1	salicylhydroxamic acid (SHAM)IBA 12/2019
1	GlycosaminoglycansIBA 12/2019
1	Acetylcysteine (Siran)FDA LinkGeneric 09/2018
1	Thioacetamide (Thioacetamid)IBA 01/2018
1	4-hydroxybenzyl isothiocyanateIBA 01/2018
1	SolutionsIBA 01/2018
1	diallyl trisulfideIBA 11/2017
1	Suppositories (Vaginal Suppositories)IBA 10/2017
1	sodium sulfideIBA 10/2017
1	Indicators and Reagents (Reagents)IBA 10/2017
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 04/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2017
1	AntioxidantsIBA 04/2017
1	Taurine FDA Link 01/2014
1	prostatic acid phosphataseIBA 11/2004